TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Parental tolerance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: fewer medical office visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Postoperative pain scores at rest and during coughing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of rescue analgesics used
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Intentions to quit smoking in the next month
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intentions to reduce smoking in the next 6 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mask-wearing intentions in the next 2 weeks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: downtime
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Maximum concentration (Cmax) of ibuprofen and acetaminophen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall drug exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PGA treatment success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean per cent reduction in mPASI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to suck feed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of neurological problems at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Severity of anxiety, depression and obsession
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: degree of repigmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patients' level of satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of 30-day readmission or ED visit
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Subjective ratings of intoxication
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Functional connectivity between nucleus accumbens and prefrontal cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution of obstructive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: H-reflex latencies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Homosynaptic depression at 2 Hz
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Gamma passing rate (GPR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PTV Dmean
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinically significant PCa detection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Maternal reassurance score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maternal satisfaction score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Kt/Vurea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sarcopenia remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ASAS 40 response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of new nodules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mean reduction in monthly TPB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stress induced by fundoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Crying score during fundoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: new-onset hyperuricemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total health-related quality of life (QoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: FAPSI-8 scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning
Primary endpoint: Tidal volume index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Positive end-expiratory pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: IDO levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: KIR2DL1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: NKG2D levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: ARIA-E occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Prevention of morbidity (resolved/improved or prevented)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS scores for vertiginous sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Enjoyment (PE)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total Quality of Recovery (TQR)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Wellness Scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Use of strategies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in Modified Ashworth Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neuromuscular and connective tissue outcomes
Primary endpoint: improve kidney health
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: improve general health
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery rates of intestinal sounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Time of the first passage of flatus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: PSS: NICU score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Energy consumed assessment reliability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Bacteria Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cognitive and neurological abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: prognostic accuracy rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and feasibility of capecitabine + Ra223
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of symptomatic skeletal events
Endpoint domain: Adverse events/effects
Primary endpoint: Time to extra-skeletal progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality at 36 weeks
Endpoint domain: Mortality/survival
Primary endpoint: Apgar scores at 10 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for antiparkinson treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Successful anesthesia induction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of stroke at 90 days
Endpoint domain: Mortality/survival
Primary endpoint: Induction of ovulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Grade 3 hand-foot skin reaction
Endpoint domain: Adverse events/effects
Primary endpoint: resting-state functional connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Prevalence of visual impairment based on presenting visual acuity value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient knowledge of blood pressure values
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Caregiver ratings for recommending the program
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: EEDE increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Shoulder muscle activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Internal rotation range of motion (IR ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rotator cuff muscle strength ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visit attendance for individual visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: angular deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: entry point deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: apical deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: DS frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PCS scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Odds of any antibiotic prescription
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delay in filling a prescription
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prescription durations greater than 7 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SNOT-22 improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Surgery referral rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: postsurgical wound infection
Endpoint domain: Adverse events/effects
Primary endpoint: unplanned revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Sensitivity of radiomic nomogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reunification outcome
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Attachment outcome
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in FMD at 1-min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Plasma levels of nitrate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Plasma levels of nitrite
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: American College of Rheumatology criteria for 50% improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CGI-S for gait/balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MDS-UPDRS-III
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Timed-Up-and-Go
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of patients with a primary end-point event
Endpoint domain: Mortality/survival
Primary endpoint: more severe or life-threatening serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Acceptability of pharmacist-delivered HPV vaccination
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: H. pylori reinfection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median site start-up time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: clinical cure for BV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lactobacilli species counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QOL Index
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: RAAS parameter reactivity to acute psychosocial stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Risk of pulmonary embolism (PE)
Endpoint domain: Mortality/survival
Primary endpoint: Cost to prevent one PE
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improvement in mobility function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum DAO activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: binge eating tendencies
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: disinhibition
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mean time to delivery/treatment failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neonatal composite endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numeric Rating Scale (NRS‐11) for pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average daily index joint pain reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WOMAC Pain or Physical Function response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-hour ambulatory systolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 24-hour ambulatory diastolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Office systolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: General health index scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean overall symptom reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in days reporting moderate-to-severe patient symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in SHS exposure at home
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: suturing assessment scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Responsibility for antenatal care
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Comprehensive antenatal care counseling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Visiting women at home during pregnancy
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: general health scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Likelihood of CVD events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: BARC type 3 to 5 bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: mean change in estimated glomerular filtration rate (eGFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: composite efficacy failure of treated biopsy‐proven acute rejection (tBPAR), graft loss, or death
Endpoint domain: Mortality/survival
Primary endpoint: HCC recurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Interobserver agreement for the Geissler classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inter-reader agreement (Dice similarity coefficient)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity for lesion detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time-saving efficiency
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: upgrade rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: life expectancy increase
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: cost per life year gained
Endpoint domain: Resource use
Primary endpoint: Gray Matter Volume (GMV) changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cumulative incidence of glycated hemoglobin level of 7.0% or higher
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Heart failure-related hospitalizations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Likelihood of respiratory failure within the first 72 hours of life
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Safety indicators (death, hospice, re‐presentation after discharge)
Endpoint domain: Adverse events/effects
Primary endpoint: Children's acceptance of SQ-LNS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinically important breathlessness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptance of medication changes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean change in gluteal and posterior thigh pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean aided pure tone average
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean functional gains
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AzBio scores in +5 dB SNR condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite renal end point
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Postoperative Quality of Life (QOL) measured by SF-12v2 questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Attitude towards Pap smear
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean hemoglobin increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness and safety of IFB in treating PELD pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk indicators for suicide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lifetime suicidal ideation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lifetime suicide attempt histories
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Itch relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EASI score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity for SSI diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRCS (Colorectal Cancer Screening Rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hospital readmission at 30 days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: hospital readmission at 90 days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Volume increase after 6 months (mm3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean soft tissue thickness increase after 6 months (mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurological function (NIH Stroke Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognitive function (Montreal Cognitive Assessment)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognitive function (Alzheimer's Disease Assessment Scale-Cognitive)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mean daily BG concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean percentage of readings within target BG of 70‐180 mg/dl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: proportion of patients with BG <70 mg/dl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Shorter hospitalization period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BIA parameters (impedance, resistance, reactance)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urine output volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in special occasion drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Past quit attempts
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to first peritonitis episode
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Hazard of peritonitis
Endpoint domain: Adverse events/effects
Primary endpoint: Ease of use reported by physicians
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Likelihood to remain in place
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Reduction in monthly MHDs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in MSQ Role Function-Restrictive score
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: 5-year cumulative incidence of HF hospital presentations after anthracyclines
Endpoint domain: Mortality/survival
Primary endpoint: 5-year cumulative incidence of HF hospital presentations after trastuzumab
Endpoint domain: Mortality/survival